HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Parotid Gland Cancer

Parotid gland cancer is a rare form of malignancy that originates in the parotid glands, which are the largest salivary glands located on either side of the face, just in front of the ears. These glands produce saliva, playing a crucial role in digestion and oral health. The development of cancer in the parotid glands is relatively uncommon, accounting for a small percentage of all head and neck cancers. Typically, tumors in the parotid glands may be benign, but a subset can be malignant, posing a more serious health risk. Symptoms of parotid gland cancer may include a painless lump or swelling in the gland, facial weakness or paralysis, persistent pain in the area, difficulty swallowing, and changes in facial appearance. However, it's important to note that these symptoms can also be indicative of non-cancerous conditions. Diagnosis involves a thorough examination by a medical professional, including imaging studies such as ultrasound, CT scans, and MRI. Additionally, a biopsy may be conducted to confirm the presence of cancer cells. Treatment options for parotid gland cancer depend on various factors, including the stage of cancer, the extent of tumor spread, and the overall health of the patient. Common approaches include surgery to remove the tumor, radiation therapy to target cancer cells, and in some cases, chemotherapy may be recommended. The prognosis for parotid gland cancer varies, but early detection and intervention significantly improve the chances of successful treatment. Regular check-ups, prompt medical attention for any concerning symptoms, and a collaborative approach between healthcare providers and patients are crucial in managing this condition effectively.

Committee Members
Speaker at International Cancer Conference 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Cancer Conference 2026 - Patricia Tai

Patricia Tai

UpToDate, Canada
Speaker at International Cancer Conference 2026 - Jose Manuel Cervera Grau

Jose Manuel Cervera Grau

Preclinical Lab and Computational Drug Discovery Program, Relayer Biotech Inc, Spain

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp